Patient-Controlled Access Registry Aids in Image Sharing
A patient-controlled registry allows imaging data to be shared without placing undue burdens on the patients, providers or infrastructures.
Use of a patient-controlled access registry allows imaging data to be shared between unaffiliated health care facilities without placing undue burdens on the patients, providers or infrastructures, said researchers in an article published by the Journal of the American Informatics Association.
Researchers from Wake Forest School of Medicine in Winston-Salem, N.C., built a patient-controlled access-key registry (PCARE), which allowed participating patients to electronically verify their identities. The goal was to avoid having patients hand-deliver images or CDs, or burdensome requests to be sent between institutions.
Through the PCARE portal, access keys were issued by the image source facilities and when the keys were digitally signed by the patients for requesting facilities, the images became available for retrieval. In addition to ease of information transfer, this type of system would help protect patient privacy, the authors said.
“The same framework can also be used to realize a longitudinal virtual electronic health record,” the authors wrote.
A prototype has been implemented to demonstrate the feasibility of such a framework, as well as the benefits of the approach.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
